PEPAXTI

This brand name is authorized in Austria, Croatia, Estonia, Ireland, Italy, Lithuania.

Active ingredients

The drug PEPAXTI contains one active pharmaceutical ingredient (API):

1
UNII 3412470A0V - MELPHALAN FLUFENAMIDE HYDROCHLORIDE
 

Melphalan is a bifunctional alkylating agent. Formation of carbonium intermediates from each of the two bis-2-chloroethyl groups enables alkylation through covalent binding with the 7-nitrogen of guanine on DNA, cross-linking the two DNA strands and thereby preventing cell replication.

 
Read more about Melphalan

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 PEPAXTI Powder for concentrate for solution for infusion MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
L01AA10 L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01A Alkylating agents → L01AA Nitrogen mustard analogues
Discover more medicines within L01AA10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 3036619
IT Agenzia del Farmaco 050299015
LT Valstybinė vaistų kontrolės tarnyba 1095405

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.